Thursday 25 April 2024
Internal Reference Number: FOI_6444
Date Request Received: 25/01/2022 00:00:00
Date Request Replied To: 03/02/2022 00:00:00
This response was sent via: By Email
Request Summary: Usage of intra-vitreal injections or implants
Request Category: Companies
| Question Number 1: For the 4-month period from September to December 2021, how many patients has your trust treated (using intra-vitreal injections or implants) for each of the following eye conditions: • Wet Age-Related Macular Degeneration (wAMD) • Diabetic Macular Oedema (DMO) • Retinal Vein Occlusion - Central (CRVO) or Branch (BRVO) • Any other eye condition | |
| Answer To Question 1: No. of patients treated with IVT between Sept to Dec 21 Wet AMD 510 DMO 84 RVO 123 Any other eye condition 32 | |
| Question Number 2: How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from September to December 2021: • Aflibercept • Bevacizumab • Brolucizumab • Dexamethasone • Fluocinolone acetonide • Ranibizumab | |
| Answer To Question 2: Aflibercept 1602 Bevacizumab 9 Brolucizumab 0 Dexamethasone 11 Fluocinolone Acetonide 0 Ranibizumab 75 | |
| Question Number 3: Please provide the number of injections/implants by eye condition for the four-month period from September to December 2021. Please complete the table attached | |
| Answer To Question 3: Please see response below: Aflibercept Wet AMD 1131 DMO 192 RVO 211 Any other eye condition 68 Total 1602 Ranibizumab Wet AMD 67 DMO 1 RVO 5 Any other eye condition 2 Total 75 Dexamethasone Wet AMD 0 DMO 6 RVO 5 Any other eye condition 0 Total 11 Bevacizumab Wet AMD 5 DMO 0 RVO 1 Any other eye condition 3 Total 9 Fluocinolone Acetonide Wet AMD 0 DMO 0 RVO 0 Any other eye condition 0 Total 0 Brolucizumab Wet AMD 0 DMO 0 RVO 0 Any other eye condition 0 Total 0 | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
